Researchers reviewing non-blood-contact heart therapies reported in Nature Communications on August 12, 2026, that soft robotic cardiac sleeves offer an alternative to conventional blood-contact pumps. Heart failure affects more than 64 million people worldwide and carries a five-year mortality rate exceeding 50 percent. While heart transplantation remains the definitive cure, severe donor shortages leave most end-stage patients relying on mechanical circulatory support.
Existing mechanical assist options, such as axial- and centrifugal-flow ventricular assist devices, present significant clinical trade-offs. Only 10 to 15 percent of heart failure patients qualify for device implantation due to high surgical risks. Furthermore, conventional pumps make direct contact with circulating blood, driving complications including thrombosis, infection, and a lifelong requirement for anticoagulation therapy. Contemporary devices also generate continuous, non-pulsatile blood flow that deviates from natural cardiac hemodynamics.
Sleeve architecture and materials
Soft robotic sleeves avoid blood contact by surrounding the outer epicardial surface of the heart to deliver synchronized compression, torsion, and relaxation. The structural base layer utilizes soft elastomers such as medical-grade silicone or thermoplastic polyurethane. These materials match native myocardial compliance with an elastic modulus between 20 and 50 kilopascals while handling 10 to 15 percent physiological strain.
Engineers rely on multiple actuator strategies to drive external mechanical assistance. Pneumatic sleeves are currently the most mature preclinical technology. Thermally driven shape memory alloys made from nickel-titanium contract under electrical heating, while twisted and coiled polymers utilize nylon or polyethylene terephthalate fibers. Electroactive polymers offer rapid electronic deformation, though hybrid systems combining pneumatic force with electroactive precision are also under development.
Sensing, power, and clinical scope
Sleeve operation depends on embedded sensors and closed-loop control algorithms. Epicardial electrocardiogram electrodes made from platinum-iridium or gold-coated silicone detect electrical signals to trigger systolic compression. Piezoresistive or capacitive strain sensors built from liquid-metal or carbon-black composites track wall motion, while capacitive microelectromechanical sensors measure internal pressure. Multi-layer encapsulation using parylene-C or polyurethane guards internal electronics against moisture.
Power transmission is moving from percutaneous drivelines toward transcutaneous energy transfer systems. These wireless platforms use inductive coupling between external and internal coils to eliminate permanent skin penetrations, reducing chronic infection risks while transmitting telemetry data. Nature Communications did not publish a timeline for when wireless transcutaneous systems will enter human clinical trials.
Computational design pipelines for patient-specific sleeves begin with geometric reconstructions using magnetic resonance imaging or computed tomography scans. Finite element analysis models local stress distribution before physical sleeves undergo benchtop testing and ex vivo validation. Emerging designs also target biventricular mechanics, incorporating spatially resolved actuation across both left and right ventricles to prevent right ventricular failure during cardiac support.
